FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3017130668> ?p ?o ?g. }

• W3017130668 endingPage "83" @default.
• W3017130668 startingPage "74" @default.
• W3017130668 abstract "Amylin treatment improves body weight and glucose control, although it is limited by a short action and need for high doses. Dual amylin and calcitonin receptor agonists (DACRAs) are dual amylin and calcitonin receptor agonists with beneficial effects beyond those of amylin. However, to what extent the additional benefits reside in their higher potency or their targeting of the calcitonin receptor remains unclear. Here we deconstruct the receptors involved in the effects of a DACRA, KBP-088, by comparing it to rat amylin (rAMY), rat calcitonin (rCT), and their combination in obese high-fat diet (HFD) and diabetic Zucker diabetic fatty (ZDF) rats. HFD-fed Sprague-Dawley rats and ZDF rats were treated for 4 weeks with KBP-088 (5 µg/kg per day), rAMY (300 µg/kg per day), rCT (300 µg/kg per day), and the combination of rAMY and rCT (300+300 µg/kg per day) using infusion pumps. Body weight, food intake, fasting glycemia, glycated hemoglobin type A1c levels, and glucose tolerance were assessed. In obese HFD-fed rats, KBP-088, rAMY, and the combination of rAMY and rCT significantly reduced body weight and improved glucose tolerance, whereas rCT alone had no effect. In diabetic ZDF rats, rCT was efficient in lowering fasting glycemia similar to rAMY, whereas dual activation by KBP-088 and the combination of rAMY and rCT were superior to activating either receptor alone. In conclusion, calcitonin therapy regulates fasting blood glucose in a diabetic rat model, thereby underscoring the importance of calcitonin receptor activation as well as the known role of amylin receptor agonism in the potent metabolic benefits of this group of peptides. <h3>SIGNIFICANCE STATEMENT</h3> We deconstruct the receptors activated by dual amylin and calcitonin receptor agonist (DACRA) therapy to elucidate through which receptor the beneficial metabolic effects of the DACRAs are mediated. We show that calcitonin receptor activation is important for blood glucose regulation in diabetes. This is in addition to the known metabolic beneficial role of amylin receptor activation. These data help in understanding the potent metabolic benefits of the DACRAs and underline the potential of DACRAs as treatment for diabetes and obesity." @default.
• W3017130668 created "2020-04-24" @default.
• W3017130668 creator A5049421061 @default.
• W3017130668 creator A5062465642 @default.
• W3017130668 creator A5066080561 @default.
• W3017130668 creator A5077488254 @default.
• W3017130668 creator A5082542112 @default.
• W3017130668 date "2020-04-21" @default.
• W3017130668 modified "2023-09-23" @default.
• W3017130668 title "The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy" @default.
• W3017130668 cites W1492946553 @default.
• W3017130668 cites W1627681056 @default.
• W3017130668 cites W1974885750 @default.
• W3017130668 cites W1976026154 @default.
• W3017130668 cites W1979143337 @default.
• W3017130668 cites W1980139145 @default.
• W3017130668 cites W1982906016 @default.
• W3017130668 cites W1986267285 @default.
• W3017130668 cites W1988441237 @default.
• W3017130668 cites W2004092276 @default.
• W3017130668 cites W2008730189 @default.
• W3017130668 cites W2013389100 @default.
• W3017130668 cites W2013698751 @default.
• W3017130668 cites W2036645926 @default.
• W3017130668 cites W2041263309 @default.
• W3017130668 cites W2042350426 @default.
• W3017130668 cites W2045554373 @default.
• W3017130668 cites W2047741142 @default.
• W3017130668 cites W2063133381 @default.
• W3017130668 cites W2065786925 @default.
• W3017130668 cites W2066625980 @default.
• W3017130668 cites W2075691591 @default.
• W3017130668 cites W2088989468 @default.
• W3017130668 cites W2093340710 @default.
• W3017130668 cites W2114626270 @default.
• W3017130668 cites W2117309485 @default.
• W3017130668 cites W2134775254 @default.
• W3017130668 cites W2138623655 @default.
• W3017130668 cites W2151846672 @default.
• W3017130668 cites W2157652680 @default.
• W3017130668 cites W2163848442 @default.
• W3017130668 cites W2166810828 @default.
• W3017130668 cites W2169116402 @default.
• W3017130668 cites W2170571946 @default.
• W3017130668 cites W2171015095 @default.
• W3017130668 cites W2289668220 @default.
• W3017130668 cites W2325068822 @default.
• W3017130668 cites W2429044373 @default.
• W3017130668 cites W2486533473 @default.
• W3017130668 cites W2578922157 @default.
• W3017130668 cites W2596005234 @default.
• W3017130668 cites W2609525834 @default.
• W3017130668 cites W2727387565 @default.
• W3017130668 cites W2888033685 @default.
• W3017130668 cites W2901896934 @default.
• W3017130668 cites W2941916221 @default.
• W3017130668 cites W3234128 @default.
• W3017130668 cites W4233210933 @default.
• W3017130668 cites W4239813584 @default.
• W3017130668 cites W4241223668 @default.
• W3017130668 cites W4244516946 @default.
• W3017130668 cites W433553030 @default.
• W3017130668 doi "https://doi.org/10.1124/jpet.119.263392" @default.
• W3017130668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32317372" @default.
• W3017130668 hasPublicationYear "2020" @default.
• W3017130668 type Work @default.
• W3017130668 sameAs 3017130668 @default.
• W3017130668 citedByCount "15" @default.
• W3017130668 countsByYear W30171306682021 @default.
• W3017130668 countsByYear W30171306682022 @default.
• W3017130668 countsByYear W30171306682023 @default.
• W3017130668 crossrefType "journal-article" @default.
• W3017130668 hasAuthorship W3017130668A5049421061 @default.
• W3017130668 hasAuthorship W3017130668A5062465642 @default.
• W3017130668 hasAuthorship W3017130668A5066080561 @default.
• W3017130668 hasAuthorship W3017130668A5077488254 @default.
• W3017130668 hasAuthorship W3017130668A5082542112 @default.
• W3017130668 hasBestOaLocation W30171306681 @default.
• W3017130668 hasConcept C118303440 @default.
• W3017130668 hasConcept C126322002 @default.
• W3017130668 hasConcept C134018914 @default.
• W3017130668 hasConcept C163170386 @default.
• W3017130668 hasConcept C165220095 @default.
• W3017130668 hasConcept C170493617 @default.
• W3017130668 hasConcept C2777180221 @default.
• W3017130668 hasConcept C2777538456 @default.
• W3017130668 hasConcept C2778938600 @default.
• W3017130668 hasConcept C2779627488 @default.
• W3017130668 hasConcept C2780705028 @default.
• W3017130668 hasConcept C555293320 @default.
• W3017130668 hasConcept C71924100 @default.
• W3017130668 hasConcept C92316933 @default.
• W3017130668 hasConceptScore W3017130668C118303440 @default.
• W3017130668 hasConceptScore W3017130668C126322002 @default.
• W3017130668 hasConceptScore W3017130668C134018914 @default.
• W3017130668 hasConceptScore W3017130668C163170386 @default.
• W3017130668 hasConceptScore W3017130668C165220095 @default.
• W3017130668 hasConceptScore W3017130668C170493617 @default.

• next